Esophageal Adenocarcinoma Clinical Trials in Orange, California

4 studies are recruiting for esophageal adenocarcinoma in Orange, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    This study is open to adults aged 18 years and older with different types of HER2+ cancer that has spread and cannot be removed by surgery. People can take part in this study if their tumours show HER2 aberrations and previous treatment was not successful. The purpose of this study is to find a sui…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of California Irvine, Orange, California
    Locations
    105 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT06324357 on ClinicalTrials.gov

  2. ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

    This is a proof of principle clinical trial determining efficacy of single dose dualimmune checkpoint inhibitors to increase intra-tumoral T cells in esophageal, gastroesophageal junction, and gastric adenocarcinomas. These are subjects who have not previously been treated for their disease, who ar…

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California
    Run by
    University of California, Irvine

    See if you can join NCT06824363 on ClinicalTrials.gov

  3. First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

    A multicenter, single-arm, first-in-human study to investigate the safety, pharmacokinetics, and preliminary antitumor activity of PLX-61639 in participants with locally advanced or metastatic, relapsed/refractory, SMARCA4-deficient solid tumors who are intolerant of or have failed available, appro…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, Orange, California
    Locations
    10 in total
    Run by
    Plexium, Inc.

    See if you can join NCT07284186 on ClinicalTrials.gov

  4. Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

    This is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 (givastomig) in subjects with advanced or metastatic solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Stern Center for Cancer Clinical Trials and Research, Orange, California
    Locations
    21 in total
    Run by
    I-Mab Biopharma US Limited

    See if you can join NCT04900818 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.